A clonal population with abnormal cytogenetics or somatic mutation(s) but no S3FB1 mutation, BCR-ABL1 translocation, or other genetic abnormalities of myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion should be identified. This evidence concerns the gene BCR and lymphoid neoplasm.